mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.4 |
mRNA |
VAF-347 |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.4 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
LY-2157299 |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.4 |
mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.4 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.4 |
mRNA |
PF-3758309 |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.4 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.4 |
mRNA |
ABT-888 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |